Interim results from an open-label extension study of briakinumab for the treatment of moderate to severe psoriasis

被引：0
|
作者：
Langley, Richard G. [1 ]
Williams, David [2 ]
Papp, Kim [3 ]
Olds, Michele [2 ]
机构：
[1] Dalhousie Univ, Halifax, NS, Canada
[2] Abbott Labs, Abbott Pk, IL 60064 USA
[3] Prob Med Res, Waterloo, ON, Canada
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2012年 / 66卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
下载
收藏
页码：AB195 / AB195
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of briakinumab for treatment of moderate to severe psoriasis in patients previously receiving etanercept: Results from an open-label extension
    Strober, Bruce
    Leonardi, Craig
    Williams, David A.
    Olds, Michele
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 66 (04) : AB191 - AB191
  • [2] Long-term safety and efficacy of ABT-874 for the treatment of moderate to severe psoriasis: Interim analysis from an open-label extension study
    Langley, Richard
    Valdes, Joaquin
    Gordon, Kenneth
    Papp, Kim
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 64 (02) : AB148 - AB148
  • [3] Safety results from a pooled analysis of randomized, controlled phase II and III clinical trials and interim data from an open-label extension trial of the interleukin-12/23 monoclonal antibody, briakinumab, in moderate to severe psoriasis
    Langley, R. G.
    Papp, K.
    Gottlieb, A. B.
    Krueger, G. G.
    Gordon, K. B.
    Williams, D.
    Valdes, J.
    Setze, C.
    Strober, B.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2013, 27 (10) : 1252 - 1261
  • [4] The use of hyaluronic acid in the treatment of moderate to severe nasolabial folds: Results from an open-label extension trial
    Narins, Rhoda
    Maas, Corey
    Jones, Derek
    Monheit, Gary
    Coleman, William, III
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 62 (03) : AB62 - AB62
  • [5] Bimekizumab efficacy and safety up to two years in patients with moderate to severe plaque psoriasis switching from ustekinumab: Results from the interim BE BRIGHT open-label extension trial
    Leonardi, Craig
    Sator, Paul
    Morita, Akimichi
    Kokolakis, Georgios
    Blauvelt, Andrew
    Warren, Richard
    De Cuyper, Dirk
    Madden, Cynthia
    Vanvoorden, Veerle
    Wang, Maggie
    Foley, Peter
    Papp, Kim
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2022, 63 : 13 - 14
  • [6] Effisayil ON, an open-label, long-term extension study of spesolimab treatment in patients with generalized pustular psoriasis: interim results for flare treatment
    Navarini, Alexander A.
    Bachelez, Herve
    Choon, Siew Eng
    Jaya, Subang
    Burden, A. David
    Zheng, Min
    Morita, Akimichi
    Tanaka, Yuko
    Ye, Binqi
    Thoma, Christian
    Lebwohl, Mark G.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB44 - AB44
  • [7] Efficacy and safety of briakinumab in moderate to severe psoriasis patients with prior failure to TNF antagonist: Subanalysis of a 52-week phase III trial and open-label extension
    Gordon, Kenneth
    Strober, Bruce
    Williams, David
    Olds, Michele
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 66 (04) : AB191 - AB191
  • [8] A single-center, open-label study assessing the efficacy of excimer in combination with clobetasol spray and calcitriol ointment for the treatment of moderate to severe psoriasis: Updated interim results
    Sorenson, Eric
    Nguyen, Catherine
    Beroukhim, Kourosh
    Leon, Argentina
    Danesh, Melissa
    Malakouti, Mona
    Brown, Gabrielle
    Huynh, Monica
    Levin, Ethan
    Debbaneh, Maya
    Koo, John
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB223 - AB223
  • [9] Ongoing open-label extension study of ecallantide for the treatment of acute attacks of hereditary angioedema: interim results
    MacGinnitie, A.
    Pullman, W.
    Patrick, H.
    ALLERGY, 2010, 65 : 13 - 14
  • [10] Infliximab for severe, treatment resistant psoriasis: a prospective, open-label study
    Smith, CH
    Jackson, K
    Bashir, S
    Chew, A
    Powell, A
    Perez, A
    Wain, M
    Barker, JNWN
    BRITISH JOURNAL OF DERMATOLOGY, 2006, 154 (01)
12345